- Home
- KSCP vs INKT Comparison
KSCP vs INKT Comparison
Compare KSCP & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSCP
- INKT
- Stock Information
- Founded
- KSCP 2013
- INKT 2017
- Country
- KSCP United States
- INKT United States
- Employees
- KSCP N/A
- INKT N/A
- Industry
- KSCP Telecommunications Equipment
- INKT Medicinal Chemicals and Botanical Products
- Sector
- KSCP Telecommunications
- INKT Health Care
- Exchange
- KSCP Nasdaq
- INKT Nasdaq
- Market Cap
- KSCP 35.9M
- INKT 75.7M
- IPO Year
- KSCP 2022
- INKT 2021
- Fundamental
- Price
- KSCP $5.59
- INKT $16.54
- Analyst Decision
- KSCP Strong Buy
- INKT Hold
- Analyst Count
- KSCP 3
- INKT 3
- Target Price
- KSCP $15.67
- INKT $37.50
- AVG Volume (30 Days)
- KSCP 1.0M
- INKT 3.0M
- Earning Date
- KSCP 08-13-2025
- INKT 08-12-2025
- Dividend Yield
- KSCP N/A
- INKT N/A
- EPS Growth
- KSCP N/A
- INKT N/A
- EPS
- KSCP N/A
- INKT N/A
- Revenue
- KSCP $11,468,000.00
- INKT N/A
- Revenue This Year
- KSCP $16.17
- INKT N/A
- Revenue Next Year
- KSCP $39.02
- INKT N/A
- P/E Ratio
- KSCP N/A
- INKT N/A
- Revenue Growth
- KSCP N/A
- INKT N/A
- 52 Week Low
- KSCP $2.45
- INKT $4.56
- 52 Week High
- KSCP $28.57
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- KSCP 40.74
- INKT 49.27
- Support Level
- KSCP $7.30
- INKT $16.02
- Resistance Level
- KSCP $10.14
- INKT $20.25
- Average True Range (ATR)
- KSCP 0.97
- INKT 8.31
- MACD
- KSCP -0.31
- INKT -1.23
- Stochastic Oscillator
- KSCP 1.09
- INKT 0.86
About KSCP Knightscope Inc.
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.